scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1468-3083.2009.03537.X |
P698 | PubMed publication ID | 20015170 |
P2093 | author name string | J Schmitt | |
D E Ford | |||
P433 | issue | 8 | |
P921 | main subject | circulatory system | Q11068 |
P304 | page(s) | 885-892 | |
P577 | publication date | 2009-12-10 | |
P1433 | published in | Journal of the European Academy of Dermatology and Venereology | Q15760872 |
P1476 | title | Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. | |
P478 | volume | 24 |
Q89970104 | A systematic review and meta-analysis of the association between psoriasis and hypertension with adjustment for covariates |
Q48063769 | Adalimumab retreatment successfully restores clinical response and health-related quality of life in patients with moderate to severe psoriasis who undergo therapy interruption |
Q54967829 | Association between psoriasis and asthma risk: A meta-analysis. |
Q34381490 | Association of psoriasis with stroke and myocardial infarction: meta-analysis of cohort studies |
Q57403239 | Associations Between Non-neurological Autoimmune Disorders and Psychosis: A Meta-analysis |
Q55135968 | Associations between site of skin lesions and depression, social anxiety, body-related emotions and feelings of stigmatization in psoriasis patients. |
Q47218445 | Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis |
Q51009674 | Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis. |
Q38076496 | Cardiovascular aspects of psoriasis: an updated review |
Q34812877 | Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review |
Q40031011 | Cardiovascular risk factors in subjects with psoriasis: a cross-sectional general population study |
Q33823950 | Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. |
Q90261441 | Cohort profile: the clinical 'Psoriasis in Adolescents' (PIA) cohort in Denmark |
Q34140480 | Comorbidities and cardiovascular risk factors in patients with psoriasis |
Q46625469 | Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study |
Q39417482 | Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression |
Q64903242 | Diagnostic and therapeutic guidelines for plaque psoriasis - Brazilian Society of Dermatology. |
Q37268868 | Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis |
Q45983342 | Epidemiology of mental health comorbidity in psoriasis. |
Q38098647 | Examining the risk of cardiovascular disease in patients with psoriasis: a critical review. |
Q34497024 | Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study |
Q31098137 | Increased overall drug utilization in patients with psoriasis: a case-control study based on Dutch general practitioner data |
Q37954016 | Management of psoriasis and its comorbidities in primary care |
Q37420435 | Primary care-based screening for cardiovascular risk factors in patients with psoriasis. |
Q44942262 | Psoriasis and increased risk of ischemic stroke in Taiwan: a nationwide study |
Q36824796 | Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies |
Q37449514 | Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study |
Q46838241 | Psoriasis as initiator or amplifier of the systemic inflammatory march: impact on development of severe vascular events and implications for treatment strategy. |
Q34643790 | Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis |
Q43693973 | Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study |
Q37969835 | Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments |
Q38114903 | Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis |
Q37475408 | Psychosomatic paradigms in psoriasis: Psoriasis, stress and mental health |
Q36741063 | Rapid improvement of palmoplantar psoriasis after cessation of smoking. |
Q36515160 | Risk and predictors of cardiovascular disease in psoriasis: a population-based study |
Q38983615 | Risk of depression in women with psoriasis: a cohort study |
Q46048754 | Risk of myocardial infarction in psoriasis patients: a retrospective cohort study. |
Q38056160 | The association between psoriasis and dyslipidaemia: a systematic review |
Q38064779 | The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies |
Q38702268 | The association between the clinical diversity of psoriasis and depressive symptoms: the HUNT Study, Norway |
Q39358289 | The experience of having psoriasis through the lens of the International Classification of Functioning, Disability and Health (ICF). |
Q26862537 | The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis |
Q84441860 | [Current topics in psoriasis] |
Q87140366 | [Genome-associated studies in chronic inflammatory dermatoses] |
Search more.